Macquarie Group LTD Bio Techne Corp Transaction History

Macquarie Group LTD

$87.4 Billion
Q1 2024

A detailed history of Macquarie Group LTD transactions in Bio Techne Corp stock. As of the latest transaction made, Macquarie Group LTD holds 2,533,673 shares of TECH stock, worth $196 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

2,533,673

Previous 2,511,872 0.87%

Holding current value

$196 Million

Previous $194 Million 7.98%

% of portfolio

0.2%

Previous 0.23%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$65.98 - $77.09 $1.44 Million - $1.68 Million	21,801 Added 0.87%	2,533,673 $178 Million
Q4 2023 Feb 14, 2024	BUY	$52.83 - $78.22 $2.18 Million - $3.22 Million	41,221 Added 1.67%	2,511,872 $194 Million
Q3 2023 Nov 14, 2023	BUY	$67.52 - $89.42 $23.7 Million - $31.3 Million	350,299 Added 16.52%	2,470,651 $168 Million
Q2 2023 Aug 14, 2023	BUY	$73.76 - $85.98 $12.1 Million - $14.1 Million	164,437 Added 8.41%	2,120,352 $173 Million
Q1 2023 May 15, 2023	BUY	$71.62 - $86.62 $23.2 Million - $28 Million	323,246 Added 19.8%	1,955,915 $145 Million

Q4 2022 Feb 21, 2023	BUY	$80.67 - $352.29 $101 Million - $442 Million	1,254,625 Added 331.87%	1,632,669 $135 Million
Q3 2022 Nov 14, 2022	BUY	$282.54 - $391.85 $587,683 - $815,048	2,080 Added 0.55%	378,044 $107 Million
Q2 2022 Aug 15, 2022	SELL	$322.67 - $449.65 $3.08 Million - $4.29 Million	-9,533 Reduced 2.47%	375,964 $130 Million
Q1 2022 May 16, 2022	BUY	$353.85 - $487.79 $9.66 Million - $13.3 Million	27,291 Added 7.62%	385,497 $167 Million
Q4 2021 Feb 11, 2022	BUY	$456.15 - $525.06 $1.19 Million - $1.37 Million	2,605 Added 0.73%	358,206 $185 Million
Q3 2021 Nov 12, 2021	SELL	$444.87 - $538.88 $2.83 Million - $3.43 Million	-6,366 Reduced 1.76%	355,601 $172 Million
Q2 2021 Aug 13, 2021	BUY	$387.35 - $450.26 $123 Million - $143 Million	318,145 Added 725.99%	361,967 $163 Million
Q1 2021 May 14, 2021	SELL	$314.62 - $411.0 $20.8 Million - $27.1 Million	-66,037 Reduced 60.11%	43,822 $16.7 Million
Q4 2020 Feb 16, 2021	SELL	$246.9 - $321.87 $572,067 - $745,772	-2,317 Reduced 2.07%	109,859 $34.9 Million
Q3 2020 Nov 13, 2020	SELL	$232.22 - $282.96 $2.01 Million - $2.45 Million	-8,659 Reduced 7.17%	112,176 $27.8 Million
Q2 2020 Aug 11, 2020	SELL	$185.43 - $279.56 $174,118 - $262,506	-939 Reduced 0.77%	120,835 $31.9 Million
Q1 2020 May 15, 2020	SELL	$161.17 - $221.51 $995,385 - $1.37 Million	-6,176 Reduced 4.83%	121,774 $23.1 Million
Q4 2019 Feb 14, 2020	BUY	$189.68 - $222.09 $1.15 Million - $1.34 Million	6,044 Added 4.96%	127,950 $28.1 Million
Q3 2019 Nov 14, 2019	SELL	$183.56 - $216.72 $1.13 Million - $1.34 Million	-6,178 Reduced 4.82%	121,906 $23.9 Million
Q2 2019 Aug 14, 2019	SELL	$188.72 - $215.43 $6.73 Million - $7.69 Million	-35,681 Reduced 21.79%	128,084 $26.7 Million
Q1 2019 May 15, 2019	SELL	$136.09 - $200.44 $1.65 Million - $2.43 Million	-12,118 Reduced 6.89%	163,765 $32.5 Million
Q4 2018 Feb 15, 2019	SELL	$132.75 - $203.8 $503,255 - $772,605	-3,791 Reduced 2.11%	175,883 $25.5 Million
Q3 2018 Nov 15, 2018	BUY	$147.44 - $204.11 $648,441 - $897,675	4,398 Added 2.51%	179,674 $36.7 Million
Q2 2018 Aug 14, 2018	SELL	$144.9 - $165.58 $3.1 Million - $3.55 Million	-21,417 Reduced 10.89%	175,276 $25.9 Million
Q1 2018 May 11, 2018	BUY	$131.46 - $151.04 $535,173 - $614,883	4,071 Added 2.11%	196,693 $29.7 Million
Q4 2017 Feb 15, 2018	SELL	$121.17 - $134.75 $901,262 - $1 Million	-7,438 Reduced 3.72%	192,622 $25 Million
Q3 2017 Nov 08, 2017	BUY	$113.59 - $123.78 $22.7 Million - $24.8 Million	200,060	200,060 $24.2 Million

Others Institutions Holding TECH

# of Institutions

581

Shares Held

154M

Call Options Held

180K

Put Options Held

189K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $3.03B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account

Macquarie Group LTD Bio Techne Corp Transaction History